The emerging therapy of this peptide represents a major development in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets multiple pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide010075.articlesblogger.com/64497127/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment